한국어
English
日本語
中文(简体)
Sutiro Tablet 100 mg (Bedaquiline Fumarate)
120.89mg
Tablet · Prescription medication
Korea Janssen Co., Ltd.
Bedaquiline fumarate is an antituberculosis ingredient used in the treatment of multidrug-resistant tuberculosis.
MFDS ingredient code M259110
Bedaquiline fumarate is an antituberculosis agent that selectively inhibits ATP synthase, which is essential for energy production in tuberculosis bacteria. It is mainly used for the treatment of multidrug-resistant tuberculosis and effectively suppresses bacteria resistant to existing drugs.
Bedaquiline fumarate blocks the function of ATP synthase within the tuberculosis bacteria, preventing the cells from producing energy. As a result, the tuberculosis bacteria struggle to survive and proliferate, leading to therapeutic efficacy.
Approved uses differ by product. Check each product's information for its actual use.
Unlike conventional tuberculosis treatments, Bedaquiline fumarate targets ATP synthase, making it effective against multidrug-resistant tuberculosis. This ingredient is characterized by its ability to shorten treatment duration and help overcome resistance.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.